Pharmacy-based bone mineral density screening found that 78% of patients were unware of their risk of fractures and 70% of the moderate or high risk patients referred to a physician actually visited the doctor and 24% of those patients were started on therapy, according to the Project ImPACT: Osteoporosis study.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.